Skip to main content
Top
Published in: Rheumatology International 5/2013

01-05-2013 | Original Article

Orange–brown chromonychia, a novel finding in Kawasaki disease

Authors: Priyankar Pal, Prabhas Prasun Giri

Published in: Rheumatology International | Issue 5/2013

Login to get access

Abstract

Kawasaki disease (KD) is one of the commonest vasculitis of childhood, where diagnosis is clinical based on a plethora of signs and symptoms. One of the typical findings is the changes in the extremities including the nail changes. Orange–brown chromonychia is a colour change in the nails which has been observed in some cases of KD. Here, we report a series of 40 patients of KD, where a typical transverse orange–brown discolouration of nails or chromonychia was noted in 29 patients. Though chromonychia is noted in many other rheumatic and nonrheumatic diseases, the typical transverse orange–brown chromonychia observed in KD patients can be included as an additional clinical feature in diagnosis of KD.
Literature
1.
go back to reference Freedberg IM (2003) Fitzpatrick’s dermatology in general medicine, 6th edn. McGraw-Hill, New York Freedberg IM (2003) Fitzpatrick’s dermatology in general medicine, 6th edn. McGraw-Hill, New York
2.
go back to reference Lindsley CB (1992) Nail-bed lines in Kawasaki disease. Am J Dis Child 146:659–660PubMed Lindsley CB (1992) Nail-bed lines in Kawasaki disease. Am J Dis Child 146:659–660PubMed
3.
go back to reference Ciastko AR (2002) Onychomadesis and Kawasaki disease. Can Med Assoc J 166:1069 Ciastko AR (2002) Onychomadesis and Kawasaki disease. Can Med Assoc J 166:1069
4.
go back to reference Vanderhooft SL, Vanderhooft JE (1999) Pincer nail deformity after Kawasaki’s disease. J Am Acad Dermatol 41:341–342PubMedCrossRef Vanderhooft SL, Vanderhooft JE (1999) Pincer nail deformity after Kawasaki’s disease. J Am Acad Dermatol 41:341–342PubMedCrossRef
5.
6.
go back to reference Unamuno P, Fernández-López E, Santos C (1992) Leukonychia due to cytostatic agents. Clin Exp Dermatol 17(4):273–274PubMedCrossRef Unamuno P, Fernández-López E, Santos C (1992) Leukonychia due to cytostatic agents. Clin Exp Dermatol 17(4):273–274PubMedCrossRef
7.
go back to reference Dasanu CA, Vaillant JG, Alexandrescu DT (2006) Distinct patterns of chromonychia, Beau’s lines, and melanoderma seen with vincristine, adriamycin, dexamethasone therapy for multiple myeloma. Dermatol Online J 12(6):10PubMed Dasanu CA, Vaillant JG, Alexandrescu DT (2006) Distinct patterns of chromonychia, Beau’s lines, and melanoderma seen with vincristine, adriamycin, dexamethasone therapy for multiple myeloma. Dermatol Online J 12(6):10PubMed
8.
go back to reference Shellow WV, Koplon BS (1968) Green striped nails: chromonychia due to Pseudomonas aeruginosa. Arch Dermatol 97:149–153PubMedCrossRef Shellow WV, Koplon BS (1968) Green striped nails: chromonychia due to Pseudomonas aeruginosa. Arch Dermatol 97:149–153PubMedCrossRef
9.
go back to reference Monsel G, Ly F, Canestri A, Diousse P, Ndiaye B, Caumes E (2008) Prevalence of skin disorders in HIV patients in Senegal and relationship to degree of immunosuppression. Ann Dermatol Venereol 135(3):187–193 (in French)PubMedCrossRef Monsel G, Ly F, Canestri A, Diousse P, Ndiaye B, Caumes E (2008) Prevalence of skin disorders in HIV patients in Senegal and relationship to degree of immunosuppression. Ann Dermatol Venereol 135(3):187–193 (in French)PubMedCrossRef
10.
go back to reference Thapa R, Pal P (2010) Transverse orange–brown chromonychia in Kawasaki disease. Int J Dermol 49(2):227–228CrossRef Thapa R, Pal P (2010) Transverse orange–brown chromonychia in Kawasaki disease. Int J Dermol 49(2):227–228CrossRef
Metadata
Title
Orange–brown chromonychia, a novel finding in Kawasaki disease
Authors
Priyankar Pal
Prabhas Prasun Giri
Publication date
01-05-2013
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 5/2013
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-012-2521-2

Other articles of this Issue 5/2013

Rheumatology International 5/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.